TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32404076

Group type: EXPERIMENTAL
Intervention: Gamification using a board game
Number of subjects: 94

Group type: COMPARATOR
Intervention: Conventional lecture
Number of subjects: 94
Study: 86073140

Group type: EXPERIMENTAL
Intervention: Intranasal glucagon (1 mg) plus sodium glycocholate (15 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous glucagon
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intramuscular glucagon
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surfactant alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Glucagon alone
Number of subjects: 0
Study: 36257222

Group type: EXPERIMENTAL
Intervention: Magic recreation program (6 weeks)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Usual activities (control group)
Number of subjects: 12
Study: 32852358

Group type: EXPERIMENTAL
Intervention: Prescribed walking program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 33895682

Group type: EXPERIMENTAL
Intervention: Regorafenib
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 34732357

Group type: EXPERIMENTAL
Intervention: Danhong injection (DHI)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 33827145

Group type: EXPERIMENTAL
Intervention: Adapted psychological interventions for depression delivered by trained health professionals alongside a supporter
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Supporters' involvement in therapy
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Regular clinical supervision
Number of subjects: 27
Study: 34980828

Group type: EXPERIMENTAL
Intervention: AH Plus
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Pulp Canal Sealer
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: NeoSEALER Flo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: EndoSequence BC
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Super‐Bond RC Sealer
Number of subjects: 100
Study: 32135454

Group type: EXPERIMENTAL
Intervention: Isolated rapid eye movement sleep behavior disorder (iRBD) patients
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: iRBD patients
Number of subjects: 37
Study: 35352600

Group type: EXPERIMENTAL
Intervention: CBIA (app-based cognitive-behavioral intervention)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: CBIA + CC (app-based cognitive-behavioral intervention supplemented with telephone conference calls)
Number of subjects: 87

Group type: COMPARATOR
Intervention: ACG (attention control group)
Number of subjects: 87
Study: 32107160

Group type: EXPERIMENTAL
Intervention: Reiki intervention applied preoperatively, details on dosage and duration not available.
Number of subjects: 210

Group type: COMPARATOR
Intervention: Control group (no Reiki intervention).
Number of subjects: 210
Study: 32721578

Group type: EXPERIMENTAL
Intervention: Current asthma education program + placement of two indoor air cleaners in the family's home
Number of subjects: 0

Group type: COMPARATOR
Intervention: Current asthma education program
Number of subjects: 0
Study: 35100970

Group type: EXPERIMENTAL
Intervention: High RV pacing burden (hRVP: ≥ 40%)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Low RV pacing burden (lRVP < 40%)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups (hRVP and lRVP)
Number of subjects: 60
Study: 34036355

Group type: EXPERIMENTAL
Intervention: Zinc-biofortified wheat (10.9 mg zinc/d, 0.6 g total phytate/d)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Zinc supplementation (25 mg/d) in MP3
Number of subjects: 36
Study: 35798633

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 40

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 40
Study: 33464703

Group type: EXPERIMENTAL
Intervention: EXE + DAPA
Number of subjects: 30

Group type: COMPARATOR
Intervention: PLAC + DAPA
Number of subjects: 30
Study: 36104135

Group type: EXPERIMENTAL
Intervention: Maximal surgical resection followed by chemoradiotherapy plus adjuvant chemotherapy for 6 months with neoadjuvant chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maximal surgical resection followed by chemoradiotherapy plus adjuvant chemotherapy for 6 months with extended adjuvant chemotherapy until progression
Number of subjects: 0

Group type: COMPARATOR
Intervention: Maximal surgical resection followed by chemoradiotherapy plus adjuvant chemotherapy for 6 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Extended adjuvant chemotherapy until progression
Number of subjects: 0
Study: 32931545

Group type: EXPERIMENTAL
Intervention: Wuqinxi (WQX) exercise programme
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 68
Study: 34311119

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy for sleep disturbance and fatigue (CBT‐SF)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Health education (HE)
Number of subjects: 51
Study: 35397352

Group type: EXPERIMENTAL
Intervention: Real TENS (frequency 100 Hz, pulse width 200 microseconds, voltage 2 mA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sham TENS
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Real TENS
Number of subjects: 100
Study: 34058254

Group type: EXPERIMENTAL
Intervention: Preoperative SRS
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Subtotal resection (STR)
Number of subjects: 242
Study: 32077404

Group type: EXPERIMENTAL
Intervention: BRA intervention
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 73
Study: 35418091

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (2 capsules/day for 6 weeks containing L.acidophilus, L.plantarum, L.fermentum, L.Gasseri, and fructo-oligo-saccharides)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 35698099

Group type: EXPERIMENTAL
Intervention: Communication Bridge™ intervention (dyadic intervention based in communication participation therapy models)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control intervention (non-dyadic intervention based in impairment therapy models)
Number of subjects: 90
Study: 34450120

Group type: EXPERIMENTAL
Intervention: Precision vestibular rehabilitation (VESTIB) for 30 minutes/day for 4 weeks
Number of subjects: 55

Group type: COMPARATOR
Intervention: Behavioral management control (CONTROL) for 30 minutes/day for 4 weeks
Number of subjects: 55
Study: 35704507

Group type: EXPERIMENTAL
Intervention: Slow-paced diaphragmatic breathing exercise
Number of subjects: 171
Study: 34303862

Group type: EXPERIMENTAL
Intervention: Bayesian two-stage adaptive design for MinED-based dosing-finding trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Random scenario generative algorithm for MinED
Number of subjects: 0
Study: 34578873

Group type: EXPERIMENTAL
Intervention: 800 mg DHA/day
Number of subjects: 543

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 543
Study: 33362392

Group type: EXPERIMENTAL
Intervention: Postoperative early enteral nutrition (EEN) + parenteral nutrition (PN)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Total parenteral nutrition (TPN)
Number of subjects: 60
Study: 33666898

Group type: EXPERIMENTAL
Intervention: 10% carbamide peroxide overnight tray system
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 36156443

Group type: EXPERIMENTAL
Intervention: Muvity telerehabilitation system
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 10
Study: 34704711

Group type: EXPERIMENTAL
Intervention: 5 mL normal saline
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: 10 mL normal saline
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: 20 mL normal saline
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control (baseline measurement)
Number of subjects: 71
Study: 32660833

Group type: EXPERIMENTAL
Intervention: 12 mg⋅day−1 astaxanthin for 7 days
Number of subjects: 12

Group type: COMPARATOR
Intervention: Appearance-matched placebo for 7 days
Number of subjects: 12
Study: 33098856

Group type: EXPERIMENTAL
Intervention: Berotralstat 110 mg
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Berotralstat 150 mg
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study: 32785021

Group type: EXPERIMENTAL
Intervention: Muscle5 supplement (M5) with home-based resistance exercise (HBRE)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (PLA) with home-based resistance exercise (HBRE)
Number of subjects: 32
Study: 35797029

Group type: EXPERIMENTAL
Intervention: Technology-based information and coaching/support program
Number of subjects: 102
Study: 34825640

Group type: EXPERIMENTAL
Intervention: Rehabilitation exercises (REs) of lower limbs and instructions of daily care (ID-C) for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Instructions of daily care (ID-C) only for 12 weeks
Number of subjects: 0
Study: 32182310

Group type: EXPERIMENTAL
Intervention: High-fat diet + 7% 'Ziluolan' (F)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: High-fat diet + 5% 'Ziluolan' (E)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: High-fat diet + 7% 'Suzhouqing' (D)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: High-fat diet (B)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Normal diet (A)
Number of subjects: 56
Study: 34759239

Group type: EXPERIMENTAL
Intervention: Pudendal nerve block with 5 mL bupivacaine 0.5% with adrenaline 1:200,000
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group receiving local wound infiltration
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Pudendal nerve block
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study: 33902667

Group type: EXPERIMENTAL
Intervention: Point-of-care cardiopulmonary ultrasound examination
Number of subjects: 211

Group type: COMPARATOR
Intervention: Standard clinical examination alone
Number of subjects: 211
Study: 36476152

Group type: EXPERIMENTAL
Intervention: Fibrinogen concentrate
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 32674392

Group type: EXPERIMENTAL
Intervention: Community-led total sanitation (CLTS) intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Existing local government program
Number of subjects: 0
Study: 34915106

Group type: COMPARATOR
Intervention: 0 g protein water control (WC)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 12.5 g low-dose protein (LP)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 50.0 g high-dose protein (HP)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Dose-rising protein beverage
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Multivariate models incorporating multiple biomarkers
Number of subjects: 24
Study: 32064499

Group type: EXPERIMENTAL
Intervention: Temozolomide (TMZ)
Number of subjects: 369

Group type: COMPARATOR
Intervention: Radiotherapy (RT)
Number of subjects: 369
Study: 35346735

Group type: EXPERIMENTAL
Intervention: Low-intensity acute aerobic exercise for 20 minutes
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Moderate-intensity acute aerobic exercise for 20 minutes
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: High-intensity acute aerobic exercise for 20 minutes
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (watched a 20-minute documentary)
Number of subjects: 160
Study: 34120448

Group type: EXPERIMENTAL
Intervention: GRS‐WHR324 (waist‐to‐hip ratio)
Number of subjects: 795

Group type: EXPERIMENTAL
Intervention: GRS‐BMI565 (body mass index)
Number of subjects: 795

Group type: EXPERIMENTAL
Intervention: GRS‐VAT208 (visceral adipose tissue)
Number of subjects: 795

Group type: EXPERIMENTAL
Intervention: GRS‐BF81 (body fat)
Number of subjects: 795
Study: 32589229

Group type: EXPERIMENTAL
Intervention: Active vitamin supplementation
Number of subjects: 3365

Group type: EXPERIMENTAL
Intervention: Active garlic supplementation
Number of subjects: 3365

Group type: COMPARATOR
Intervention: Placebo for vitamin supplementation
Number of subjects: 3365

Group type: COMPARATOR
Intervention: Placebo for garlic supplementation
Number of subjects: 3365
Study: 35565100

Group type: EXPERIMENTAL
Intervention: Mediterranean style dietary pattern with high intensity interval training (HIIT)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 23
Study: 32726566

Group type: EXPERIMENTAL
Intervention: 6% CHO MR solution
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 12
Study: 34579122

Group type: EXPERIMENTAL
Intervention: PPN with periOlimel N4‐E
Number of subjects: 156

Group type: COMPARATOR
Intervention: Conventional fluid therapy
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: High-risk BC
Number of subjects: 156
Study: 34319864

Group type: EXPERIMENTAL
Intervention: Weighted vest (20 lb for males, 14 lb for females) during running trials
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Weighted vest (20 lb for males, 14 lb for females) during walking trials at 10% gradient
Number of subjects: 20

Group type: COMPARATOR
Intervention: No weighted vest during walking and running trials
Number of subjects: 20
Study: 33711781

Group type: EXPERIMENTAL
Intervention: Paliperidone palmitate 3-monthly (PP3M)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Paliperidone palmitate 1-monthly (PP1M)
Number of subjects: 159
Study: 32246728

Group type: EXPERIMENTAL
Intervention: Low ascending doses of oral NTX (NTX/BUP, n=50)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo (PBO-N/BUP, n=51)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Low ascending doses of oral NTX (NTX/BUP)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo (PBO-N/BUP)
Number of subjects: 101
Study: 35513899

Group type: EXPERIMENTAL
Intervention: Once-daily fixed combination of bimatoprost 0.01%, brimonidine tartrate 0.15%, and timolol maleate 0.5%
Number of subjects: 30

Group type: COMPARATOR
Intervention: Twice-daily fixed combination of bimatoprost 0.01%, brimonidine tartrate 0.15%, and timolol maleate 0.5%
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Once-daily fixed combination
Number of subjects: 30

Group type: COMPARATOR
Intervention: Twice-daily fixed combination
Number of subjects: 30
Study: 34742270

Group type: EXPERIMENTAL
Intervention: Internal mammary node irradiation (IMNI)
Number of subjects: 1800

Group type: COMPARATOR
Intervention: No internal mammary node irradiation (IMNI)
Number of subjects: 1800
Study: 34723897

Group type: EXPERIMENTAL
Intervention: Media-based educational materials
Number of subjects: 135

Group type: COMPARATOR
Intervention: Print-based educational materials
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Both media and print-based educational materials
Number of subjects: 135
Study: 32046415

Group type: EXPERIMENTAL
Intervention: Leuprolide acetate treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cetrorelix treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable (comparison of leiomyoma to myometrium)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable (immunohistochemical analysis)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable (qRT-PCR results)
Number of subjects: 0
Study: 33269876

Group type: EXPERIMENTAL
Intervention: Sprint Interval Training (SIT)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Combined Aerobic + Resistance Training (COMB)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Usual Care Control
Number of subjects: 52
Study: 32717123

Group type: EXPERIMENTAL
Intervention: 12-week aerobic exercise intervention
Number of subjects: 24
Study: 36189993

Group type: EXPERIMENTAL
Intervention: 20 IU/kg NM57
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 40 IU/kg NM57
Number of subjects: 60

Group type: COMPARATOR
Intervention: 20 IU/kg HRIG
Number of subjects: 60
Study: 32240476

Group type: EXPERIMENTAL
Intervention: MDGP external umbilicus treatment, twice a week for 4 weeks.
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo control group, twice a week for 4 weeks.
Number of subjects: 72
Study: 32167484

Group type: EXPERIMENTAL
Intervention: Dutasteride 0.5 mg daily for 8 weeks before HoLEP
Number of subjects: 402
Study: 33150816

Group type: EXPERIMENTAL
Intervention: SHP465 mixed amphetamine salts (MAS) extended-release
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32981933

Group type: EXPERIMENTAL
Intervention: Probiotic drink (fermented milk containing Lactobacillus casei strain Shirota) 65 mL/day with 108 CFU/mL for 12 weeks
Number of subjects: 1003

Group type: COMPARATOR
Intervention: Control group (no probiotic intervention)
Number of subjects: 1003
Study: 36074775

Group type: EXPERIMENTAL
Intervention: PACTS (patient-delivered household contact tracing and prevention for tuberculosis)
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: PACTS
Number of subjects: 214

Group type: COMPARATOR
Intervention: SOC (standard of care)
Number of subjects: 214

Group type: COMPARATOR
Intervention: SOC
Number of subjects: 214
Study: 33914402

Group type: EXPERIMENTAL
Intervention: Trauma Comorbidity Index (TCI)
Number of subjects: 84903

Group type: COMPARATOR
Intervention: Charlson and Elixhauser comorbidity indices
Number of subjects: 84903
Study: 34872390

Group type: EXPERIMENTAL
Intervention: Intervention with poetry (G1) - reading a booklet about values and principles of professional ethics and poems for 1 month
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Intervention without poetry (G2) - reading the booklet without poetry
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (G3) - no intervention
Number of subjects: 108
Study: 32946821

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 5 mg
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg
Number of subjects: 251

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 251
Study: 36157386

Group type: EXPERIMENTAL
Intervention: Individualised exercise training using ventilatory thresholds
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Standardised exercise training using a percentage of heart rate reserve
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (convenience sample)
Number of subjects: 38
Study: 32339234

Group type: EXPERIMENTAL
Intervention: Motivational interviewing and tailored counselling on medication adherence
Number of subjects: 1009

Group type: COMPARATOR
Intervention: Usual medical care
Number of subjects: 1009
Study: 35637458

Group type: EXPERIMENTAL
Intervention: Neck-specific exercises (NSE)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Internet-supported neck-specific exercises (NSEIT)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: NSEIT and NSE
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Physiotherapists' self-efficacy and confidence in diagnosing and treating patients with neck pain
Number of subjects: 20
Study: 34485522

Group type: EXPERIMENTAL
Intervention: Pharmacophore model AAARRR.1061
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Molecular docking analysis of compound STOCK2S-23597
Number of subjects: 62
Study: 36233791

Group type: EXPERIMENTAL
Intervention: Cognitive-Behavior Therapy delivered by Videoconference (VCP)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Face-to-Face Cognitive-Behavior Therapy
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Cognitive-Behavior Therapy (both VCP and Face-to-Face)
Number of subjects: 148
Study: 34619419

Group type: EXPERIMENTAL
Intervention: Progressive relaxation exercises
Number of subjects: 84

Group type: COMPARATOR
Intervention: Standard nursing interventions
Number of subjects: 84
Study: 34000628

Group type: EXPERIMENTAL
Intervention: Prolonged release-fampridine (10 mg b.i.d.)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 33770278

Group type: EXPERIMENTAL
Intervention: 3 + 1 technique (bipolar electrocoagulation catheter)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Direct-stroke technique (bipolar electrocoagulation catheter)
Number of subjects: 148
Study: 34545448

Group type: EXPERIMENTAL
Intervention: Venovo venous stent
Number of subjects: 170
Study: 34050763

Group type: EXPERIMENTAL
Intervention: Synbiotic supplementation with lifestyle modifications
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo with lifestyle modifications
Number of subjects: 0
Study: 33234137

Group type: EXPERIMENTAL
Intervention: Pretreatment with ticagrelor
Number of subjects: 2520

Group type: EXPERIMENTAL
Intervention: Downstream administration of prasugrel
Number of subjects: 2520

Group type: EXPERIMENTAL
Intervention: Downstream administration of ticagrelor
Number of subjects: 2520

Group type: COMPARATOR
Intervention: No pretreatment (control group)
Number of subjects: 2520
Study: 36429386

Group type: EXPERIMENTAL
Intervention: Virtual environment practice
Number of subjects: 22

Group type: COMPARATOR
Intervention: Real environment practice
Number of subjects: 22
Study: 32416251

Group type: EXPERIMENTAL
Intervention: Alpelisib plus fulvestrant
Number of subjects: 571

Group type: EXPERIMENTAL
Intervention: Preventive anti-rash medication
Number of subjects: 571

Group type: EXPERIMENTAL
Intervention: More-detailed AE management guidelines
Number of subjects: 571

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 571
Study: 34260650

Group type: EXPERIMENTAL
Intervention: ELO water
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control water (tap water)
Number of subjects: 150
Study: 32237060

Group type: EXPERIMENTAL
Intervention: Synergy everolimus-eluting stents (EES)
Number of subjects: 783

Group type: COMPARATOR
Intervention: Resolute Integrity zotarolimus-eluting stents (ZES)
Number of subjects: 783

Group type: EXPERIMENTAL
Intervention: Orsiro sirolimus-eluting stents (SES)
Number of subjects: 783
Study: 33527886

Group type: EXPERIMENTAL
Intervention: e-CTA (Brainomix)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Physicians (neuroradiologist, radiology resident, two neurology residents)
Number of subjects: 301
Study: 34152012

Group type: EXPERIMENTAL
Intervention: Salpingectomy
Number of subjects: 4040

Group type: EXPERIMENTAL
Intervention: Hysterectomy
Number of subjects: 4040

Group type: EXPERIMENTAL
Intervention: Tubal ligation
Number of subjects: 4040
Study: 33087054

Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) received a 16-hour educational workshop on the Brazilian Dietary Guidelines (BDG)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 24